Investigational Oral Medication for Weight Management
This study is evaluating an investigational oral medication for adults living with obesity or who are overweight. Researchers are exploring whether this investigational treatment may help support weight management and improve related health outcomes over time, while closely monitoring participant safety and wellbeing throughout the study.
Study overview
Living with obesity or excess weight can affect many aspects of health and daily life. Weight-related health conditions may include high blood pressure, high cholesterol or abnormal blood fats, obstructive sleep apnoea, cardiovascular disease, coronary artery disease, and fatty liver disease. Although lifestyle changes and currently available treatments may help some people, additional treatment approaches are still being investigated.
Am I eligible?
You may be eligible if:
- Are aged 18–79 years
- Have a BMI ≥30 kg/m² or have a BMI ≥27 kg/m² with a weight-related health condition such as high blood pressure, high cholesterol, sleep apnoea (breathing problems during sleep), heart disease, blocked heart arteries, or fatty liver disease
Participants currently taking GLP-1 receptor agonists or DPP-4 inhibitors will not be eligible.
Indicative only. Eligibility is confirmed by our team at screening.
What taking part involves
If eligible, you will take part in the study for up to approximately 81 weeks. Throughout the study, participants will attend approximately 18 clinic visits and 5 phone calls. Clinic visits are fasted visits, meaning morning appointment availability is essential.
Researchers will closely monitor participants’ health, wellbeing, and safety through regular check-ins and assessments. Study procedures may include physical examinations, blood tests, ECGs, weight and BMI measurements, questionnaires, and other routine health checks.
Participants in this study will be randomly assigned to receive either the study treatment (at different dose levels) or a placebo. There is a 30% chance of receiving the placebo.
- 1
Enquiry & phone call
We call to explain the study and answer your questions.
- 2
Screening visit
Meet the team and have health checks to confirm eligibility.
- 3
Study visits
Regular visits with expert care and health monitoring.
- 4
Final visit & follow-up
A wrap-up check and a thank-you for helping research.

Still have questions?
Our team is happy to talk it through. Call 1300 742 326.
Frequently asked questions
A clinical trial is a research study involving volunteers that helps researchers evaluate new treatments, medications, medical devices or approaches to healthcare. Clinical trials help determine whether these interventions are safe, effective and appropriate for wider use.
Clinical trials help advance healthcare by showing how treatments work, identifying possible side effects and exploring new ways to prevent, diagnose and manage medical conditions. By taking part, volunteers contribute to knowledge that may benefit people in the future.
Each trial has its own eligibility criteria, which may relate to your age, medical history, health conditions or current medications. Some studies are for people with a specific condition, while others involve healthy volunteers. Our research team can help you understand whether a study may be suitable.
Participant safety and wellbeing are central to clinical research. In Australia, trials must meet strict ethical and regulatory requirements and are reviewed by a Human Research Ethics Committee (HREC). Participants are monitored throughout the study.
All clinical trials involve some uncertainty and level of risk. Before you decide, the research team will explain the known and potential risks, possible benefits and available alternatives.
